SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001144204-17-048544
Filing Date
2017-09-18
Accepted
2017-09-18 18:02:53
Documents
1
Period of Report
2017-09-14

Document Format Files

Seq Description Document Type Size
1 FORM 4 v475391_form4.html 4  
1 FORM 4 v475391_form4.xml 4 4148
  Complete submission text file 0001144204-17-048544.txt   5651
Mailing Address 430 EAST 29TH STREET SUITE 940 NEW YORK NY 10016
Business Address 430 EAST 29TH STREET SUITE 940 NEW YORK NY 10016 646-440-9310
IMMUNE PHARMACEUTICALS INC (Issuer) CIK: 0001208261 (see all company filings)

IRS No.: 521841431 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O BRAINSTORM CELL THERAPEUTICS, INC. 605 THIRD AVENUE, 34TH FLOOR NEW YORK NY 10158
Business Address
Fiorino Anthony S. (Reporting) CIK: 0001608901 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36602 | Film No.: 171090648